ADMA Biologics is a biopharmaceutical company relentlessly committed to creating superior products for immunodeficient patients at risk for infection. It is our devotion to this underserved population that fuels us and our hands-on approach to production and development that sets us apart. If you are looking for a dynamic, innovative, growing company in the biopharmaceutical industry that is committed to excellence and integrity, then consider ADMA Biologics. We currently have an exciting opportunity available for an
The Integration Analyst designs, develops, and supports enterprise data integration solutions, ETL processes, APIs, and business applications to enable secure, reliable, and scalable data exchange across enterprise systems. This role collaborates with business and technical teams to deliver high-quality data integration solutions that support operational reporting, analytics, and business processes.
Education Requirements: Bachelor’s degree in Computer Science, Information Systems, Software Engineering, or a related technical discipline.
Experience Requirements: Proven experience developing ETL solutions using Pentaho or equivalent ETL platforms. Strong SQL and relational database development experience. Programming skills in languages like Python, R, Java or Lucene. Hands-on experience with data lake technologies, including Elasticsearch. Experience developing ezeScreens applications, workflows, and business process automation. Experience designing and developing REST APIs and enterprise system integrations. Experience integrating cloud, database, file-based, and enterprise applications. Knowledge of data warehousing, data modeling, and data governance principles. Experience with Power BI, Tableau, or similar BI platforms.
Experience in pharmaceutical, biotechnology, healthcare, or regulated environments and experience with cloud-based integration platforms and DevOps practices preferred.
The minimum compliance expectation for this role entails strict adherence to FDA regulations and company policies governing sales and marketing activities. This includes completion of required compliance training, accurate documentation of sales interactions, and adherence to data privacy regulations. Additionally, the role requires proactive participation in compliance reviews, prompt reporting of any potential issues, and ongoing education to stay updated on relevant FDA regulations.
In addition to competitive compensation, we offer a comprehensive benefits package including:
ADMA Biologics uses E-Verify to confirm the employment eligibility of all newly hired employees. To learn more about E-Verify, including your rights and responsibilities, please visit www.dhs.gov/E-Verify.
ADMA Biologics is an Equal Opportunity Employer.
ADMA Biologics is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. ADMA currently manufactures and markets three United States Food and Drug Administration (FDA) approved plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases: BIVIGAM® (immune globulin intravenous, human) for the treatment of primary humoral immunodeficiency (PI); ASCENIV™ (immune globulin intravenous, human – slra 10% liquid) for the treatment of PI; and NABI-HB® (hepatitis B immune globulin, human) to provide enhanced immunity against the hepatitis B virus. ADMA manufactures its immune globulin products at its FDA-licensed plasma fractionation and purification facility located in Boca Raton, Florida. Through its ADMA BioCenters subsidiary, ADMA also operates as an FDA-approved source plasma collector in the U.S., which provides a portion of its blood plasma for the manufacture of its products. ADMA’s mission is to manufacture, market and develop specialty plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases and management of immune compromised patient populations who suffer from an underlying immune deficiency, or who may be immune compromised for other medical reasons. ADMA has received U.S. Patents: 9,107,906, 9,714,283, 9,815,886, 9,969,793 and 10,259,865 related to certain aspects of its products and product candidates. For more information, please visit www.admabiologics.com.
